Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease

  • Authors: Judith S. Currier, MD, MSc; Risa Hoffman, MD, MPH (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 10/10/18 (What's New)

Summary

  • ACC/AHA guidelines on management of blood cholesterol recommend moderate- or high-intensity statin therapy in 4 target populations (Table 3) (Management Guidelines)[ACC/AHA 2013]
    • HIV providers should recognize that these guidelines do not consider contributions of HIV and ART to risk and weigh the role of HIV and ART in dyslipidemia and cardiac risk when deciding about initiation and intensity of statin therapy

Action required